Select Page
Home » Expert Content » Oral Technologies » OptiGel Bio Enables Delivery of Synthetic Oligosaccharides

OptiGel® Bio Technology Enables Oral Delivery of Synthetic Oligosaccharides

Summary: When oral bioavailability is increased, macromolecules can potentially be converted from injectable to oral drug delivery. This case study demonstrates how OptiGel® Bio technology significantly increases oral bioavailability of a synthetic oligosaccharide, thus enabling oral conversion.

Click here to download